Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.990
+0.020 (1.02%)
Dec 5, 2025, 4:00 PM EST - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $93.79 million as of December 5, 2025. Its market cap has decreased by -4.57% in one year.
Market Cap
93.79M
Enterprise Value
37.81M
1-Year Change
-4.57%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $93.79M, a decrease of -88.34%. That is a compound annual growth rate of -35.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 93.79M | 6.46% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |